Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Berger

Showing results (1001-1010 of 1,161) with videos related to

Pageof 117
Sort By:
The Journal of Molecular Diagnostics : JMD|March 30, 2021
Clinical Experience of Cerebrospinal Fluid-Based Liquid Biopsy Demonstrates Superiority of Cell-Free DNA over Cell Pellet Genomic DNA for Molecular ProfilingTejus A Bale, Soo-Ryum Yang, James P Solomon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2015
Extreme Outlier Analysis Identifies Occult Mitogen-Activated Protein Kinase Pathway Mutations in Patients With Low-Grade Serous Ovarian CancerRachel N Grisham, Brooke E Sylvester, Helen Won, et al.
NPJ Breast Cancer|August 23, 2022
ERα-LBD, an isoform of estrogen receptor alpha, promotes breast cancer proliferation and endocrine resistanceAntonio Strillacci, Pasquale Sansone, Vinagolu K Rajasekhar, et al.
Clinical and Translational Medicine|May 29, 2025
Responsiveness of different MET tumour alterations to type I and type II MET inhibitorsYonina R Murciano-Goroff, Valentina Foglizzo, Jason Chang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 8, 2023
Clinical and Genomic Landscape of FGFR3-Altered Urothelial Carcinoma and Treatment Outcomes with Erdafitinib: A Real-World ExperienceBrendan J Guercio, Michal Sarfaty, Min Yuen Teo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 30, 2016
Reliable Detection of Mismatch Repair Deficiency in Colorectal Cancers Using Mutational Load in Next-Generation Sequencing PanelsZsofia K Stadler, Francesca Battaglin, Sumit Middha, et al.
JCO Precision Oncology|September 28, 2023
Targeted Molecular Profiling of Circulating Cell-Free DNA in Patients With Advanced Hepatocellular CarcinomaDarren Cowzer, Jessica B White, Joanne F Chou, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 19, 2019
JAK2/PD-L1/PD-L2 (9p24.1) amplifications in renal cell carcinomas with sarcomatoid transformation: implications for clinical managementSounak Gupta, John C Cheville, Achim A Jungbluth, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 5, 2017
Pancreatic intraductal tubulopapillary neoplasm is genetically distinct from intraductal papillary mucinous neoplasm and ductal adenocarcinomaOlca Basturk, Michael F Berger, Hiroshi Yamaguchi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 25, 2026
A Phase II Trial of Olaparib Plus Pembrolizumab in Patients with Recurrent Copy-Number High/p53-Abnormal Endometrial CancerMaria M Rubinstein, Jennifer Y Ge, Qin Zhou, et al.
Pageof 117

Showing results (1001-1010 of 1,161) with videos related to

Sort By:
Pageof 117
The Journal of Molecular Diagnostics : JMD|March 30, 2021
Clinical Experience of Cerebrospinal Fluid-Based Liquid Biopsy Demonstrates Superiority of Cell-Free DNA over Cell Pellet Genomic DNA for Molecular ProfilingTejus A Bale, Soo-Ryum Yang, James P Solomon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2015
Extreme Outlier Analysis Identifies Occult Mitogen-Activated Protein Kinase Pathway Mutations in Patients With Low-Grade Serous Ovarian CancerRachel N Grisham, Brooke E Sylvester, Helen Won, et al.
NPJ Breast Cancer|August 23, 2022
ERα-LBD, an isoform of estrogen receptor alpha, promotes breast cancer proliferation and endocrine resistanceAntonio Strillacci, Pasquale Sansone, Vinagolu K Rajasekhar, et al.
Clinical and Translational Medicine|May 29, 2025
Responsiveness of different MET tumour alterations to type I and type II MET inhibitorsYonina R Murciano-Goroff, Valentina Foglizzo, Jason Chang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 8, 2023
Clinical and Genomic Landscape of FGFR3-Altered Urothelial Carcinoma and Treatment Outcomes with Erdafitinib: A Real-World ExperienceBrendan J Guercio, Michal Sarfaty, Min Yuen Teo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 30, 2016
Reliable Detection of Mismatch Repair Deficiency in Colorectal Cancers Using Mutational Load in Next-Generation Sequencing PanelsZsofia K Stadler, Francesca Battaglin, Sumit Middha, et al.
JCO Precision Oncology|September 28, 2023
Targeted Molecular Profiling of Circulating Cell-Free DNA in Patients With Advanced Hepatocellular CarcinomaDarren Cowzer, Jessica B White, Joanne F Chou, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 19, 2019
JAK2/PD-L1/PD-L2 (9p24.1) amplifications in renal cell carcinomas with sarcomatoid transformation: implications for clinical managementSounak Gupta, John C Cheville, Achim A Jungbluth, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 5, 2017
Pancreatic intraductal tubulopapillary neoplasm is genetically distinct from intraductal papillary mucinous neoplasm and ductal adenocarcinomaOlca Basturk, Michael F Berger, Hiroshi Yamaguchi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 25, 2026
A Phase II Trial of Olaparib Plus Pembrolizumab in Patients with Recurrent Copy-Number High/p53-Abnormal Endometrial CancerMaria M Rubinstein, Jennifer Y Ge, Qin Zhou, et al.
Pageof 117